Cointime

DNA Script

company

About

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

  • 101 - 250

Highlights

Total Funding Amount
$217.20M
Funding Rounds
3
Investors
2

Details

Last Funding Type
Series B
Last Funding Money Raised
$50M
Industries
Biotechnology,Health Care,Life Science,Medical
Founded date
Jan 1, 2014
Number Of Employee
101 - 250
Operating Status
Active

DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$217.20M
DNA Script has raised a total of $217.20M in funding over 2 rounds. Their latest funding was raised on Nov 9, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 9, 2021 Grant $2.20M 1 National Human Genome Research Institute — Detail
Oct 26, 2021 Series C $165M 1 — — Detail
Jul 29, 2020 Series B $50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
DNA Script is funded by 2 investors. National Human Genome Research Institute and Agilent Technologies are the most recent investors.
Investor Name Lead Investor Funding Round
National Human Genome Research Institute Yes Grant
Agilent Technologies — Series C
Cointime
เนื้อหา
บริษัท